Latest News & Features
Americas
Brazil’s reforms to streamline analysis of pharmaceutical patents came into force on Monday. 14 June 2017
Americas
The US Supreme Court’s decision in the Amgen and Sandoz clash, which was handed down yesterday, has sparked disagreement between lawyers on the consequences of the ruling. 13 June 2017
Americas
The US Supreme Court has ruled that biosimilar applicants may provide notice to the manufacturer before obtaining a licence from the Food and Drug Administration for their biosimilars. 12 June 2017
Americas
Coherus BioSciences has asked a court to dismiss patent infringement allegations brought against it by Amgen. 12 June 2017
Americas
Medical device company QXMédical has filed a lawsuit against rival Vascular Solutions, denying infringement of Vascular’s patents. 12 June 2017
Americas
Eli Lilly has entered into a collaboration agreement with KeyBioscience, a subsidiary of Nordic Bioscience, to commercialise dual amylin calcitonin receptor agonists (DACRAs). 9 June 2017
Americas
The Patent Trial and Appeal Board has handed victory to hedge fund manager Kyle Bass in an inter partes review against a European healthcare company Fresenius Kabi-owned patent. 9 June 2017
Americas
Law firm Foley & Lardner has hired a new partner, Karen Mangasarian, to join its New York office. 9 June 2017
Americas
A district court has sanctioned pharmaceutical company Errant Gene Therapeutics and its counsel for violating the court's protective order. 8 June 2017
Americas
Two thirds of biotech claims challenged in inter partes reviews are directed to methods of treatment, said Brendan O’Malley, partner at Fitzpatrick Cella Harper & Scinto, at a recent industry conference. 8 June 2017